ANAlain Maertens de Noordhout

Alain Maertens de Noordhout

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Alain Maertens de Noordhout has a total of 25 co-authors. Here are the top co-authors by number of shared publications:

  • Jean Louis Pepin

    University Department of Neurology, CHR Citadelle, Liege, Belgium

    4 shared publications
  • P. J. Delwaide

    University Department of Neurology, Hôpital de la Citadelle, Liège, Belgium

    4 shared publications
  • Victor De Pasqua

    University Department of Neurology, Hôpital de la Citadelle, Boulevard du Xlleme de Ligne, 1, 4000 Liège, Belgium

    3 shared publications
  • Giovanni Pennisi

    From the University Department of Neurology (V.D., P.G., V.D.P., P.J.D., A.M.d.N.), Hôpital de la Citadelle, Liège, Belgium, and the Neurological Department (G.A., G.P., F.N.), University of Catania, Catania Italy

    2 shared publications
  • Pascale Gérard

    University Department of Neurology, Hôpital de la Citadelle, Boulevard du Xlleme de Ligne, 1, 4000 Liège, Belgium

    2 shared publications
  • Paul J. Delwaide

    From the University Department of Neurology (V.D., P.G., V.D.P., P.J.D., A.M.d.N.), Hôpital de la Citadelle, Liège, Belgium, and the Neurological Department (G.A., G.P., F.N.), University of Catania, Catania Italy

    2 shared publications

Latest Publications

  • Open Access

    Invasive and non-invasive neuromodulation in movement disorders.

    by Maertens De Noordhout Alain

    In the last 25 years, invasive electrical stimulation (DBS) of several regions of the brain has been developed to alleviate symptoms of various movement disorders. Thalamic stimulation in severe essential tremor was first shown to provide long-term relief in many patients. A few years later, similar procedures have been successful in controlling major motor signs of Parkinson's disease with electrodes located in STN or GPi, and in severe dystonia with the latter target. Even dopa-resistant freezing of gait was reportedly reduced with high frequency stimulation of pedunculopontine nucleus. However, none of these interventions has so far proven any influence on the natural course of underlying illnesses. Yet, controlled studies have confirmed that DBS significantly improves QoL of patients, at least for some years. In neurodegenerative processes an particularly PD, it seems that QoL declines over years due to the lack of control of newly appearing symptoms such as dementia and postural disturbances. Non-invasive devices including rTMS and TDCS have also been used in such disorders but their effects remain debated and, even if sometimes positive, stay transient, thus needing repeated treaatment sessions. Lack of standardization of methods may account for some discrepancy of results. In coming years, it might be that restorative techniques using viral vectors could for the first time influence the natural course of illnesses such as Parkinson's disease.

    • 1 September 2009
      • Vol. 109  (3) , 189-99

    Treatments for progressing Parkinson's disease: a clinical case scenario study.

    by Alain Maertens De Noordhout, Patrick Santens, Jean-Marie Gérard, Michel Gonce, Anne Jeanjean, Anja Flamez, Barbara Pickut, Michel Van Zandijcke, Rajesh Pahwa, Study Group Parkinson's Disease: From Guidelines to Practice in Belgium

    A 'case scenario' study on clinical decisions in progressing Parkinson's disease (PD) was developed to complement scientific evidence with the collective judgment of a panel of experts. The opinions of 9 experts in movement disorders on the appropriateness of 9 common pharmacological treatments for 33 hypothetical patient profiles were compared to those of 14 general neurologists. Before rating the case scenarios, all participants received a document integrating European and US guidelines for the treatment of patients with advanced PD. Case scenarios showing disagreement or with inconsistencies in appropriateness ratings were discussed at a feedback meeting. A tool for interactive discussion on the clinical case scenarios included was developed based on the outcome of the study. Current guidelines are often insufficient to adequately guide the management of patients with progressing PD. The case scenario study did not reveal major differences in opinions between experts in movement disorders and general neurologists about the appropriateness of certain drug choices for specific case scenarios. However in about 1 out of 5 treatment decisions where experts stated appropriateness or inappropriateness, the general neurologists panel had no or dispersed opinions. This study reveals more uncertainty about treatment of advanced PD in general neurologists compared with experts in movement disorders and underlines the need for additional support for guiding treatment decisions in clinical practice.

    • 26 August 2009
      • Vol. 5  (214) , 1650-5

    [Management of Parkinson's disease in 2009].

    by A Maertens De Noordhout

    The cause of Parkinson's disease remains unknown and no cure or prevention exists so far. Levodopa remains by far the most potent symptomatic therapy, but induces side-effects such as motor fluctuations and abnormal movements, which can somewhat be counterbalanced by optimizing levodopa plasma levels or acting at receptors level with long half-life dopamine agonists. In severe cases, functional surgery with deep brain stimulation can be offered. Some non-dopaminergic symptoms like dementia, freezing, postural instability or dysautonomia do not respond to dopaminergic drugs and need special care.

  • Dopa‐responsive parkinsonism after acute subdural hematoma

    by A. Maertens de Noordhout, F. Daenen, V. Bex


    • 1 January 2004
      • p. 170-5

    [Clinical applications of repetitive transcranial magnetic stimulation].

    by A Maertens De Noordhout

    Transcranial magnetic stimulation (TMS), when delivered in trains of pulses is able to induce long-lasting changes of excitability of neuronal networks, not only in the vicinity of the stimulating coil, but also at distant sites. Results of stimulation experiments over the motor cortex indicate that the effects (excitatory or inhibitory) depend on the frequency of stimulation. These data have prompted researchers to use repetitive transcranial magnetic stimulation (rTMS) as a therapeutic tool in various brain disorders, most notably depression. However, as long as large randomized trials have not been conducted, rTMS cannot be recommended as an alternative to validated conventional therapies of such disorders.

  • Single motor axon conduction velocities of human upper and lower limb motor units. A study with transcranial electrical stimulation

    by Francesca Dalpozzo, Pascale Gérard, Victor De Pasqua, François Wang, Alain Maertens de Noordhout


  • Ipsilateral Motor Responses to Focal Transcranial Magnetic Stimulation in Healthy Subjects and Acute-Stroke Patients

    by Giovanna Alagona, ValérIe Delvaux, Pascale GérArd, Victor De Pasqua, Giovanni Pennisi, Paul J. Delwaide, Francesco Nicoletti, Alain Maertens de Noordhout

    Background and Purpose —Prevalence and characteristics of ipsilateral upper limb motor-evoked potentials (MEPs) elicited by focal transcranial magnetic stimulation (TMS) were compared in healthy subjects and patients with acute stroke. Methods —Sixteen healthy subjects and 25 patients with acute stroke underwent focal TMS at maximum stimulator output over motor and premotor cortices. If present, MEPs evoked in muscles ipsilateral to TMS were analyzed for latency, amplitude, shape, and center of gravity (ie, preferential coil location to elicit them). In stroke patients, possible relationships between early ipsilateral responses and functional outcome at 6 months were sought. Results —With relaxed or slightly contracting target muscle, maximal TMS over the motor cortex failed to elicit ipsilateral MEPs in the first dorsal interosseous (FDI) or biceps of any of 16 normal subjects. In 5 of 8 healthy subjects tested, ipsilateral MEPs with latencies longer than contralateral MEPs were evoked in FDI muscle (in biceps, 6 of 8 subjects) during strong (>50% maximum) contraction of the target muscle. In 15 of 25 stroke patients, ipsilateral MEPs in the unaffected relaxed FDI (in biceps, 6 of 25 stroke patients) were evoked by stimulation of premotor areas of the affected hemisphere. Their latencies were shorter than those that MEPs evoked in the same muscle by stimulation of the motor cortex of the contralateral unaffected hemisphere. Such responses were never obtained in normal subjects and were mostly observed in patients with subcortical infarcts. Patients harboring these responses had slightly better bimanual dexterity after 6 months. Conclusions —Ipsilateral MEPs obtained in healthy individuals and stroke patients have different characteristics and probably different origins. In the former, they are probably conveyed via corticoreticulospinal or corticopropriospinal pathways, whereas in the latter, early ipsilateral MEPs could originate in hyperexcitable premotor areas.


  • Open Access

    Corticomotoneuronal synaptic connections in normal man

    by Alain Maertens de Noordhout, Giuseppe Rapisarda, David Bogacz, Pascale Gérard, Victor De Pasqua, Giovanni Pennisi, Paul J. Delwaide

    In order to determine the mono- or oligosynaptic character of connections between pyramidal axons and individual spinal motor neurons, we constructed peri-stimulus time histograms (PSTHs) of the firing probability of voluntarily activated single motor units (SMUs) of various upper and lower limb muscles upon slightly suprathreshold transcranial anodal electrical stimulations of the motor cortex in normal subjects. Weak anodal cortical stimuli are known to activate preferentially fast-conducting pyramidal axons directly, bypassing cell bodies and cortical interneurons. A narrow bin width (0.1 ms) was chosen to measure precisely the duration of the PSTH excitatory peak, which corresponds to the rise time of the underlying compound excitatory post-synaptic potentials (EPSP). A short duration PSTH peak indicates sharp-rising EPSPs, most commonly encountered in the case of monosynaptic connections. In flexor carpi radialis and soleus SMUs, the PSTHs of built-in responses to anodal cortical stimuli were compared with those produced by 1A afferent stimulation able to elicit a Hoffmann reflex, which is known to be largely monosynaptic. In all upper and lower limb muscles, excitable SMUs responded to anodal cortical stimuli with a highly synchronized peak of increased firing probability. In flexor carpi radialis and soleus SMUs, the mean duration of this peak was significantly narrower than that evoked by 1A afferent stimulation, indicating that monosynaptic corticomotor neuronal transmission dominates low-threshold motor units, even in proximal arm and leg muscles. In the various muscles studied, and particularly in forearm SMUs, we did not observe broad PSTH peaks against the activation of non-monosynaptic corticomotor neuronal pathways, even with near-threshold stimuli. In some triceps and forearm flexor SMUs, subthreshold anodal pulses caused significant inhibition of their voluntary firing, with a latency consistent with activation of 1A inhibitory interneurons by the descending volleys. Measurements of the maximal number of counts in the excitatory PSTH peak upon anodal cortical stimuli provide comparisons of the strength of monosynaptic inputs to various muscles which seems to be maximal for hand and finger extensor muscles, and also for deltoid.